Clinical Trial Update: Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Prothrombin Complex Concentrate to standard transfusion during/after heart transplantation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Heart Disease
• Heart Failure

Drugs mentioned

• Prothrombin Complex Concentrate (prothrombin complex concentrate)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Heart Disease End Stage, Heart Failure，Congestive | Phase 3 | Status: TERMINATED